Endo to buy DAVA Pharma for $575 million

June 24 Tue Jun 24, 2014 9:22am EDT

June 24 (Reuters) - Drugmaker Endo International Plc said it would buy privately owned DAVA Pharmaceuticals Inc for $575 million in cash.

The deal, expected to add to Endo's 2014 adjusted earnings per share, has an additional cash consideration of up to $25 million, on achieving certain sales milestones. (Reporting by Shailesh Kuber; Editing by Don Sebastian)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.